Treatment decisions in spinal muscular atrophy (SMA) are complex because of the lack of direct comparisons between therapies and the uncertainty of long-term outcomes.

Therapeutic inertia is a common phenomenon in pediatric neurologists caring for patients with SMA.

Pediatric neurologists’ aversion to ambiguity and expectation of treatment response were associated with suboptimal decisions.